Loring Wolcott & Coolidge Fiduciary Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$203K Sell
522
-44
-8% -$17.1K ﹤0.01% 276
2025
Q1
$242K Hold
566
﹤0.01% 252
2024
Q4
$233K Hold
566
﹤0.01% 268
2024
Q3
$237K Buy
566
+1
+0.2% +$419 ﹤0.01% 267
2024
Q2
$313K Buy
565
+29
+5% +$16K ﹤0.01% 232
2024
Q1
$285K Buy
536
+14
+3% +$7.45K ﹤0.01% 242
2023
Q4
$258K Sell
522
-43
-8% -$21.2K ﹤0.01% 255
2023
Q3
$255K Buy
565
+222
+65% +$100K ﹤0.01% 258
2023
Q2
$152K Buy
343
+100
+41% +$44.4K ﹤0.01% 320
2023
Q1
$112K Buy
243
+200
+465% +$92K ﹤0.01% 332
2022
Q4
$22.1K Sell
43
-3
-7% -$1.54K ﹤0.01% 460
2022
Q3
$21K Hold
46
﹤0.01% 483
2022
Q2
$22K Buy
+46
New +$22K ﹤0.01% 495
2021
Q3
Sell
-282
Closed -$108K 806
2021
Q2
$108K Buy
+282
New +$108K ﹤0.01% 391
2021
Q1
Sell
-182
Closed -$58K 429
2020
Q4
$58K Buy
+182
New +$58K ﹤0.01% 410
2019
Q4
Sell
-19
Closed -$5K 678
2019
Q3
$5K Hold
19
﹤0.01% 608
2019
Q2
$5K Hold
19
﹤0.01% 609
2019
Q1
$5K Buy
+19
New +$5K ﹤0.01% 592
2018
Q1
Sell
-106
Closed -$24K 746
2017
Q4
$24K Hold
106
﹤0.01% 495
2017
Q3
$20K Buy
106
+6
+6% +$1.13K ﹤0.01% 507
2017
Q2
$19K Hold
100
﹤0.01% 494
2017
Q1
$17K Hold
100
﹤0.01% 506
2016
Q4
$14K Hold
100
﹤0.01% 499
2016
Q3
$13K Hold
100
﹤0.01% 519
2016
Q2
$13K Buy
+100
New +$13K ﹤0.01% 521